Baxter International Stock Price, News & Analysis (NYSE:BAX)

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, July 16th. Investors of record on Friday, August 30th will be paid a dividend of $0.22 per share on Tuesday, October 1st. This represents a $0.88 annualized dividend and a yield of 1.00%. The ex-dividend date of this dividend is Thursday, August 29th. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has authorized a share repurchase program on Tuesday, November 13th 2018, which permits the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 6.1% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) posted its quarterly earnings data on Thursday, July, 25th. The medical instruments supplier reported $0.89 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.81 by $0.08. The medical instruments supplier earned $2.84 billion during the quarter, compared to analysts' expectations of $2.80 billion. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The company's revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter last year, the business posted $0.77 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Baxter International.

Baxter International will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Baxter International updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share guidance of $3.34-3.40 for the period, compared to the Thomson Reuters consensus estimate of $3.33. The company issued revenue guidance of $11.24-11.35 billion, compared to the consensus revenue estimate of $11.23 billion.

15 analysts have issued twelve-month target prices for Baxter International's stock. Their predictions range from $70.00 to $95.00. On average, they anticipate Baxter International's share price to reach $85.64 in the next twelve months. This suggests that the stock has a possible downside of 2.7%. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News articles about BAX stock have trended somewhat negative this week, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Baxter International earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Baxter International.

Baxter International saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 6,470,000 shares, an increase of 32.6% from the August 30th total of 4,880,000 shares. Based on an average trading volume of 2,380,000 shares, the short-interest ratio is currently 2.7 days. Currently, 1.3% of the company's shares are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Insulet (PODD), ABIOMED (ABMD), Novocure (NVCR), Hill-Rom (HRC), Haemonetics (HAE), Integra Lifesciences (IART) and Penumbra (PEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Honeywell International (HON), Johnson & Johnson (JNJ), Micron Technology (MU), Cisco Systems (CSCO), Pfizer (PFE) and Allergan (AGN).

Baxter International's stock is owned by many different of institutional and retail investors. Top institutional investors include Robeco Institutional Asset Management B.V. (0.36%), Gateway Investment Advisers LLC (0.06%), Envestnet Asset Management Inc. (0.05%), Meyer Handelman Co. (0.05%), Nisa Investment Advisors LLC (0.04%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Envestnet Asset Management Inc., Robeco Institutional Asset Management B.V., Decatur Capital Management Inc., Northpointe Capital LLC, CIBC Private Wealth Group LLC, CenturyLink Investment Management Co and Exane Derivatives. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue, Varma Mutual Pension Insurance Co, Meeder Asset Management Inc., TIAA FSB, Pacer Advisors Inc., Cerebellum GP LLC and DNB Asset Management AS. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $87.99.

Baxter International has a market capitalization of $44.92 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]